Literature DB >> 10997728

Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects.

M Barann1, W Meder, Z Dorner, M Brüss, H Bönisch, M Göthert, B W Urban.   

Abstract

The patch-clamp technique was used on excised (outside-out) patches to characterize h5-HT3A receptors stably transfected in HEK 293 cells and to compare the effects of the barbiturate anaesthetics methohexital and pentobarbital on this ligand-gated cation channel. At negative membrane potentials 5-HT induced inward currents in a concentration-dependent manner (EC50=8.6 microM, Hill coefficient =1.5). The mean peak current induced by 30 microM 5-HT was -110 pA at -100 mV. The 5-HT3A receptor antagonist ondansetron (0.3 nM) reversibly inhibited the 5-HT (30 microM) signal by 70% and at 3 nM it abolished the response. Methohexital and pentobarbital inhibited 5-HT-induced (30 microM) currents in a concentration-dependent manner. The maximal inhibition with a given methohexital or pentobarbital concentration was reached when the respective drug was applied 45 s prior to and during the 2-s 5-HT pulse (IC50 values=95 microM and 127 microM, Hill coefficient = -1.0 and -1.6, respectively). Although the barbiturates were, thus, equipotent, their effects differed substantially with respect to the dependence on the time schedule of application to the patches: the potency of methohexital was virtually maximal when the drug was applied exclusively 45 s before the agonist pulse, but its inhibitory potency decreased considerably when it was exclusively applied during the 2-s 5-HT pulse (IC50=380 microM). Conversely, pentobarbital was almost maximally potent in inhibiting the 5-HT signal when it was exclusively coapplied with this agonist, but its inhibitory potency was considerably lower (IC50 approximately 500 microM) when applied exclusively 45 s before 5-HT. Another difference between both barbiturates involves the rate of inactivation of 5-HT3 receptor-mediated currents: whereas high concentrations of methohexital (> or = 300 microM) were necessary to induce moderate (< or = twofold) acceleration of this parameter, pentobarbital produced such an effect at all concentrations and the extent of acceleration increased with increasing concentration (1.5- to fivefold). In conclusion, two barbiturates, chemically closely related but of different lipophilicity, clearly differ with respect to the kinetics of their effect on 5-HT3 receptor channels; one possible explanation involves drug access to an amphipathic site of action via both an aqueous and a hydrophobic pathway. Pentobarbital, in contrast to methohexital, inhibits hS-HT3A receptor-mediated currents at anaesthetic concentrations (approximately 90 microM).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997728     DOI: 10.1007/s002100000288

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Inhibition of human 5-HT(3A) and 5-HT(3AB) receptors by etomidate, propofol and pentobarbital.

Authors:  Dirk Rüsch; Hans A Braun; Hinnerk Wulf; Anika Schuster; Douglas E Raines
Journal:  Eur J Pharmacol       Date:  2007-07-13       Impact factor: 4.432

2.  Electrical interfacing of neurotransmitter receptor and field effect transistor.

Authors:  I Peitz; P Fromherza
Journal:  Eur Phys J E Soft Matter       Date:  2009-10       Impact factor: 1.890

3.  Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.

Authors:  Jan Walkembach; Michael Brüss; Bernd W Urban; Martin Barann
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

4.  Effects of opioids on human serotonin transporters.

Authors:  M Barann; U M Stamer; M Lyutenska; F Stüber; H Bönisch; B Urban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-22       Impact factor: 3.000

5.  Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.

Authors:  M Barann; G Molderings; M Brüss; H Bönisch; B W Urban; M Göthert
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

6.  Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-Jarisch reflex.

Authors:  Grzegorz Godlewski; Manfred Göthert; Barbara Malinowska
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

7.  The Role of 5-HT3 Receptors in Signaling from Taste Buds to Nerves.

Authors:  Eric D Larson; Aurelie Vandenbeuch; Anja Voigt; Wolfgang Meyerhof; Sue C Kinnamon; Thomas E Finger
Journal:  J Neurosci       Date:  2015-12-02       Impact factor: 6.167

8.  Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site.

Authors:  Sarah M Trattnig; Kasper Harpsøe; Sarah B Thygesen; Louise M Rahr; Philip K Ahring; Thomas Balle; Anders A Jensen
Journal:  J Biol Chem       Date:  2012-05-15       Impact factor: 5.157

9.  Identification of Glycyrrhiza as the rikkunshito constituent with the highest antagonistic potential on heterologously expressed 5-HT3A receptors due to the action of flavonoids.

Authors:  Robin Herbrechter; Paul M Ziemba; Katrin M Hoffmann; Hanns Hatt; Markus Werner; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2015-07-03       Impact factor: 5.810

10.  Kampo Medicine: Evaluation of the Pharmacological Activity of 121 Herbal Drugs on GABAA and 5-HT3A Receptors.

Authors:  Katrin M Hoffmann; Robin Herbrechter; Paul M Ziemba; Peter Lepke; Leopoldo Beltrán; Hanns Hatt; Markus Werner; Günter Gisselmann
Journal:  Front Pharmacol       Date:  2016-07-29       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.